capsaicin 0.000375 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.2 MG/MG Topical Ointment [Medrox]

RxCUI
2001750
RxNorm name
capsaicin 0.000375 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.2 MG/MG Topical Ointment [Medrox]
Display name
MEDROX (Topical)
Full name
capsaicin 0.000375 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.2 MG/MG Topical Ointment [Medrox]
Term type
SBD
Status
Active
Strength
0.0375-5-20%
Dose form
Ointment
Route
Topical
Updated
2026-11-06 11:18:01

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042018
Active start
042018
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
capsaicin0.000375 MG / 1 MGcapsaicincapsaicin
methyl salicylate0.2 MG / 1 MGmethyl salicylatemethyl salicylate
menthol0.05 MG / 1 MGmentholmenthol

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Ointment316985

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
capsaicin1992
methyl salicylate29787
menthol6750

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 14 matching rows.

NDC11, Source, Active table
NDC11SourceActive
45861000101rxnav_ndcsyes
45861000160rxnav_ndcsyes
50436999401rxnav_ndcsyes
63629409001rxnav_ndcsyes
68071134100rxnav_ndcsyes
68071134200rxnav_ndcsyes
33261069801rxnav_historical_indirect
33261079201rxnav_historical_indirect
35356083101rxnav_historical_indirect
52959009502rxnav_historical_indirect
52959009560rxnav_historical_indirect
68258398404rxnav_historical_indirect
68788985501rxnav_historical_indirect
68788985506rxnav_historical_indirect

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7031eb87-4378-463b-9b00-aa8fdc3dc770Medrox 0.038 % / 5 % / 20 % Topical Ointment [PSN] · capsaicin 0.000375 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.2 MG/MG Topical Ointment [Medrox] [SBD] · Medrox (capsaicin 0.000375 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.2 MG/MG) Topical Ointment [SY]33Medrox (Medroxin)20120119
771596d4-58c3-4144-99e5-7c8b3b27d1bfMedrox 0.038 % / 5 % / 20 % Topical Ointment [PSN] · capsaicin 0.000375 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.2 MG/MG Topical Ointment [Medrox] [SBD] · Medrox (capsaicin 0.000375 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.2 MG/MG) Topical Ointment [SY]32Medrox (Medroxin)20130927
1a2a7a30-9a6e-46b9-87a9-819a1ef3b78fMedrox 0.038 % / 5 % / 20 % Topical Ointment [PSN] · capsaicin 0.000375 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.2 MG/MG Topical Ointment [Medrox] [SBD] · Medrox (capsaicin 0.000375 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.2 MG/MG) Topical Ointment [SY]32Medrox (Medroxin)20110221

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
e14a98fd-3b83-46dc-a5e0-17cd55dcafa1Medrox (Medroxin)Preferred Pharmaceuticals, Inc20181130
771596d4-58c3-4144-99e5-7c8b3b27d1bfMedrox (Medroxin)Dispensing Solutions, Inc. | PSS World Medical, Inc.20130927
6ddd1867-6c39-488c-8e4f-1057c5756f31National Council for Prescription Drug Programs20120724
87e58244-310f-4c45-8f42-efff51f30e93National Council for Prescription Drug Programs20120724
91836058-33bc-473c-8401-5e7f4a0937ecNational Council for Prescription Drug Programs20120724
f17c79b0-11c7-4bef-b783-9271c5f86d18National Council for Prescription Drug Programs20120724
7031eb87-4378-463b-9b00-aa8fdc3dc770Medrox (Medroxin)H.J. Harkins Company, Inc.20120119
1a2a7a30-9a6e-46b9-87a9-819a1ef3b78fMedrox (Medroxin)Unit Dose Services20110221

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCM02ABCapsaicin and similar agentsATC1-4capsaicin
ATCN01BXOther local anestheticsATC1-4capsaicin
MEDRTD002211CapsaicinCHEMhas_ingredientcapsaicin
MEDRTD008610MentholCHEMhas_ingredientmenthol
MEDRTD012459SalicylatesCHEMhas_ingredientmethyl salicylate
MEDRTD059787Acute PainDISEASEmay_treatmethyl salicylate
MEDRTD001168ArthritisDISEASEmay_treatmethyl salicylate
MEDRTD001416Back PainDISEASEmay_treatmethyl salicylate
MEDRTD003288ContusionsDISEASEmay_treatmethyl salicylate
MEDRTD003929Diabetic NeuropathiesDISEASEmay_treatcapsaicin
MEDRTD004342Drug HypersensitivityDISEASEci_withcapsaicin
MEDRTD004342Drug HypersensitivityDISEASEci_withmenthol
MEDRTD004342Drug HypersensitivityDISEASEci_withmethyl salicylate
MEDRTD006562Herpes ZosterDISEASEmay_treatcapsaicin
MEDRTD007249InflammationDISEASEmay_treatmethyl salicylate
MEDRTD009120Muscle CrampDISEASEmay_treatmethyl salicylate
MEDRTD009437NeuralgiaDISEASEmay_treatcapsaicin
MEDRTD010146PainDISEASEmay_preventcapsaicin
MEDRTD010146PainDISEASEmay_treatmenthol
MEDRTD012871Skin DiseasesDISEASEmay_treatmenthol
MEDRTD013180Sprains and StrainsDISEASEmay_treatmethyl salicylate
MEDRTN0000000069Calcium Channel AntagonistsMOAhas_moamenthol
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moamethyl salicylate
MEDRTN0000000105Neurotransmitter Transporter InteractionsMOAhas_moacapsaicin
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moamethyl salicylate
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pemethyl salicylate
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pecapsaicin
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pementhol
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_pemethyl salicylate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.000375 MG/MG / 0.05 MG/MG / 0.2 MG/MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable SynonymMedrox 0.038 % / 5 % / 20 % Topical Ointment
SOURCESSourceMicromedex RED BOOK